SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-049874
Filing Date
2024-06-05
Accepted
2024-06-05 09:20:03
Documents
3
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0207353-6k_xtlbio.htm 6-K 17903
2 SHARE PURCHASE AGREEMENT ea020735301ex99-1_xtlbio.htm EX-99.1 228177
3 PRESS RELEASE ISSUED JUNE 5, 2024 ea020735301ex99-2_xtlbio.htm EX-99.2 15656
  Complete submission text file 0001213900-24-049874.txt   262792
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 241020948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)